EIF2A and chronic myelogenous leukemia, BCR-ABL1 positive: As a consequence of this, CML cell lines and leukemic stem cells from patient samples exhibit elevated PERK and phospho-eIF2α protein levels compared to healthy controls and expression of both is positively correlated with more advanced disease stage [12].